Alexis Guédon: Cancer-Associated Upper-Extremity Deep Vein Thrombosis
Alexis Guédon, Junior Deputy Editor at the European Journal of Preventive Cardiology, shared on LinkedIn about a recent article he and his colleagues co-authored, published in JACC Journals, adding:
“Upper-extremity deep vein thrombosis in cancer is sometimes viewed primarily as a catheter-related complication with a relatively low risk of recurrence.
In JACC Journals: CardioOncology, we report findings from 5,195 patients enrolled in the international RIETE registry, including 2,210 with active cancer.
We found that:
- Cancer was associated with higher risks of recurrent venous thromboembolism and bleeding.
- Risk differed substantially by cancer site: lung cancer had the highest recurrence risk, whereas genitourinary cancers had the highest bleeding risk.
- After anticoagulation discontinuation, the 2-year recurrence risk reached 17.2% in patients with lung cancer.
- Longer anticoagulation was associated with a lower risk of recurrence after treatment discontinuation, although these observational association should not be interpreted as causal.
These results suggest that cancer-associated upper-extremity deep vein thrombosis is more than a mechanical catheter-related complication.
Tumor biology appears to influence the balance between thrombosis and bleeding, supporting careful reassessment before anticoagulation is discontinued.
A study led by Olivier Espitia and Manuel Monreal, with the RIETE Investigators.”
Title: Upper Extremity Deep Vein Thrombosis in Cancer Patients: Clinical Course by Cancer Site
Authors: Olivier Espitia, Alexis F. Guedon, Emma Courouve, Benjamin Brenner, Juan José López-Núñez, Romain Chopard, Alicia Lorenzo, Patricia Sigüenza, Son Truong Nguye
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 28, 2026, 03:59Rahul Saha: JAMA The 49th Human Blood Group System
-
Sep 28, 2026, 01:51Ann Mullally: Expect to See Lots More Gene Therapy in Medicine in the Years Ahead
-
Sep 27, 2026, 15:49Rana Al-Hrout: Iron Deficency – Is Ferritin 15ng/mL or Less Still the Cutoff?
-
Sep 27, 2026, 15:49Ayushi Sharma: What I Thought Transfusion Medicine Would Be vs What It Actually Is
-
Sep 27, 2026, 15:48William Wallace: How Much Human Research Is Behind the Supplements We Take?
-
Sep 27, 2026, 15:46Franck Perraudin: Lp(a) Lowering Alone May Not Be Enough
-
Sep 27, 2026, 15:41Ahmed Hamandi: Sharing Real-World HSCT Experience at the Iraqi Society of Haematology Conference
-
Sep 27, 2026, 15:39Co-creating Digital Support With Young Stroke Survivors – European Stroke Organisation
-
Sep 27, 2026, 15:39Eleri Schiavone: Celebrating 80 Years of the Welsh Blood Service